Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis: differentiation from multiple atypical adenomatous hyperplasia.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 18535095)

Published in Jpn J Clin Oncol on June 05, 2008

Authors

Yoshihiro Kobashi1, Tadaaki Sugiu, Keiji Mouri, Tsutomu Irei, Masao Nakata, Mikio Oka

Author Affiliations

1: Division of Respiratory Diseases, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Japan. yoshihiro@med.kawasaki-m.ac.jp

Articles by these authors

Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest (2008) 2.68

Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J Thorac Oncol (2010) 1.73

QuantiFERON TB-2G test for patients with active tuberculosis stratified by age groups. Scand J Infect Dis (2009) 1.63

Inflammatory pseudotumor of the lung: clinicopathological analysis in seven adult patients. Int J Clin Oncol (2006) 1.55

A case of platypnea orthodeoxia syndrome: a persistent history taking was the key to the diagnosis. Intern Med (2012) 1.48

Mutational analysis of the beta-tubulin gene in lung cancer. Lung Cancer (2002) 1.48

Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma. Ann Thorac Surg (2011) 1.46

Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy. Ann Thorac Surg (2005) 1.41

A small outbreak of pulmonary tuberculosis in non-close contact patrons of a bar. Intern Med (2004) 1.39

Usefulness of tuberculin skin test and three interferon-gamma release assays for the differential diagnosis of pulmonary tuberculosis. Intern Med (2012) 1.39

The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med (2006) 1.29

Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance. Cancer Res (2005) 1.28

Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis (2006) 1.26

A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med (2006) 1.24

Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells. Lung Cancer (2005) 1.24

Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer. Cancer Lett (2003) 1.15

Expression and functional analyses of breast cancer resistance protein in lung cancer. Clin Cancer Res (2003) 1.15

Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol (2007) 1.14

Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit (2008) 1.12

Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J Infect (2008) 1.12

Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. J Infect Chemother (2006) 1.11

Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung. Clin Cancer Res (2002) 1.10

Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy. Interact Cardiovasc Thorac Surg (2012) 1.05

Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis. Intern Med (2008) 1.04

Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. J Med Microbiol (2005) 1.03

Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age. J Infect Chemother (2010) 1.03

Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period. J Infect Chemother (2011) 1.02

Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6. J Immunol (2010) 1.01

The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells. Mol Cancer Ther (2004) 1.00

Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. Int J Cancer (2002) 0.98

An indeterminate QuantiFERON TB-2G response for miliary tuberculosis, due to severe pancytopenia. J Infect Chemother (2007) 0.98

Pulmonary mucormycosis (Cunninghamella bertholletiae) with cavitation diagnosed using ultra-thin fibre-optic bronchoscopy. Respirology (2008) 0.97

A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. Int J Cancer (2011) 0.97

Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic. Int J Cancer (2004) 0.96

Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung. Lung Cancer (2007) 0.96

Four cases of pulmonary Mycobacterium avium intracellulare complex presenting as a solitary pulmonary nodule and a review of other cases in Japan. Respirology (2006) 0.95

Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells. Int J Cancer (2004) 0.94

Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers. Intern Med (2007) 0.94

CD44 is critical for airway accumulation of antigen-specific Th2, but not Th1, cells induced by antigen challenge in mice. Eur J Immunol (2011) 0.93

Sibling cases of Mycobacterium avium complex disease associated with hematological disease. J Infect Chemother (2006) 0.93

Clinicopathological analysis of multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis in Japan. Respirology (2008) 0.93

Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients. Int J Cancer (2012) 0.93

Rapid diagnosis of tuberculous pericarditis by ELISPOT assay. Scand J Infect Dis (2010) 0.92

False negative results of QuantiFERON TB-2G test in patients with active tuberculosis. Jpn J Infect Dis (2009) 0.92

Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer. Target Oncol (2012) 0.92

Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing. BMC Med Imaging (2009) 0.92

Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma. Lung Cancer (2010) 0.92

Outbreak of Chlamydophila pneumoniae infection in long-term care facilities and an affiliated hospital. J Med Microbiol (2005) 0.89

BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer. Cancer Chemother Pharmacol (2006) 0.89

Rosai-Dorfman disease presenting as a solitary mediastinal mass. Pathol Int (2009) 0.88

Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum. Gen Thorac Cardiovasc Surg (2012) 0.88

[In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007]. Jpn J Antibiot (2009) 0.88

Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: 11-years of experience. Surg Endosc (2008) 0.87

Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia. J Thorac Oncol (2011) 0.87

[Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment]. Kekkaku (2008) 0.87

Pharmacokinetics of gefitinib predicts antitumor activity for advanced non-small cell lung cancer. J Thorac Oncol (2010) 0.87

Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease. Respirology (2006) 0.86

Outbreak of pertussis in a university laboratory. Intern Med (2011) 0.86

Synchronus presentation of early-stage small cell carcinoma and adenocarcinoma in the same lung lobe. Intern Med (2006) 0.86

Clinical analysis of cases of empyema due to Streptococcus milleri group. Jpn J Infect Dis (2008) 0.86

Clinical analysis of patients with pulmonary nontuberculous mycobacterial disease complicated by pneumothorax. Intern Med (2013) 0.86

Pulmonary Mycobacterium intracellulare disease with a solitary pulmonary nodule detected at the onset of pneumothorax. J Infect Chemother (2006) 0.86

Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests. Scand J Infect Dis (2008) 0.86

Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide. Int J Cancer (2012) 0.86

Serological assay by use of glycopeptidolipid core antigen for Mycobacterium avium complex. Scand J Infect Dis (2013) 0.85

Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition. Chest (2005) 0.85

Recent results regarding the clinical impact of smoking history on postoperative complications in lung cancer patients. Interact Cardiovasc Thorac Surg (2008) 0.85

Increased levels of plasma galectin-9 in patients with influenza virus infection. Tohoku J Exp Med (2014) 0.85

High-risk populations for nasal carriage of methicillin-resistant Staphylococcus aureus. J Infect Chemother (2004) 0.85

Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines. Int J Cancer (2003) 0.84

Teratoma with malignant transformation in the anterior mediastinum. J Thorac Cardiovasc Surg (2008) 0.84

Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer. Cancer Chemother Pharmacol (2004) 0.84

Measurement of localized ground-glass attenuation on thin-section computed tomography images: correlation with the progression of bronchioloalveolar carcinoma of the lung. Invest Radiol (2002) 0.84

Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760). J Thorac Oncol (2015) 0.83

Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity. Int J Cancer (2009) 0.83

Clinical usefulness of fluoro-2-deoxy-D-glucose PET in a case with multiple bone metastases of carcinoid tumor after ten years. Intern Med (2009) 0.83